PAMELA SPARKMAN: Open Payments
NPI 1093769028 · LAKELAND, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$312 in 12 payments from 8 companies in 2025. Trend: 2023 $187 · 2024 $453 · 2025 $312
Food & beverage: $232Education: $80
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 3 | $134 |
| Organon LLC | 2 | $40 |
| ABBVIE INC. | 2 | $32 |
| GENZYME CORPORATION | 1 | $29 |
| UCB, Inc. | 1 | $23 |
| Regeneron Healthcare Solutions, Inc. | 1 | $21 |
| Galderma Laboratories, L.P. | 1 | $19 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 1 | $15 |
Products named: TREMFYA, DUPIXENT, VTAMA, SKYRIZI, Bimzelx, NEMLUVIO, Winlevi.
Industry payments across FL — which companies pay providers there.
